2012, Number 2
<< Back
Rev Mex Pediatr 2012; 79 (2)
Dyslipidemia drugs used in Pediatrics. Unitary dose
Calderón GD, Hernández GE, Barragán MG
Language: English
References: 9
Page: 109-111
PDF size: 54.59 Kb.
ABSTRACT
Pharmacological treatment of dyslipidemia in children is an option for reducing the prevalence of this metabolic disease, it is therefore necessary to expand the research studies on this type of drugs in children affected with this disease: because the medicines available have been developed for adult patients.
REFERENCES
Kusters DM, Vissers MN, Wiegman A, Kastelein JJ, Hutten BA. Treatment of dyslipidaemia in childhood. Expert Opin Pharmacother 2010; 11(5): 739-53.
Girardet JP. Anticholesteremic agents in children. Therapie 2003; 58(1): 63-7.
Soufi M, Sattler AM, Maisch B, Schaefer JR. Molecular mechanisms involved in atherosclerosis. Herz 2002; 27(7): 637-48.
Velasquez-Mieyer P, Neira CP, Nieto R, Cowan PA. Obesity and cardiometabolic syndrome in children. Ther Adv Cardiovasc Dis 2007; 1(1): 61-81.
McCrindle BW, Ose L, Marais AD. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. J Pediatr 2003; 143(1): 74-80.
Engler MM, Engler MB, Malloy M, Chiu E, Besio D, Paul S et al. Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther 2004; 42(12): 672-9.
Malinowski JM, Gehret MM. Phytosterols for dyslipidemia. Am J Health Syst Pharm 2010; 67(14): 1165-73.
Ferreira WP, Bertolami MC, Santos SN, Barros MR, de Matos Barretto RB, Pontes SC Jr et al. One-month therapy with simvastatin restores endothelial function in hypercholesterolemic children and adolescents. Pediatr Cardiol 2007; 28(1): 8-13.
Lughetti L, Bruzzi P, Predieri B. Evaluation and management of hyperlipidemia in children and adolescents. Curr Opin Pediatr 2010; 22(4): 485-93.
Full text